The role of Mbd2 in breast cancer progression has thus far been studied through gene knockdown in vitro and subsequent implantation of the generated cells into animals to establish xenograft models, in which Mbd2 depletion has shown potent anticancer effects through the inhibition and hypermethylation of prometastatic genes16,17. The gene discussed is MBD2; the disease is breast carcinoma.